OrbiMed’s Nautilus Biotechnolgy NAUT Stock Holding History

OrbiMed’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,452,774	Closed	-$7.53M	–	158
2021 Q4	$7.53M	Hold	1,452,774	–	–	0.1%	126
2021 Q3	$8.92M	Sell	1,452,774 -93,926	-6%	-$748K	0.1%	133
2021 Q2	$15.6M	Buy	1,546,700 +1,497,325	+3,033%	+$16.2M	0.16%	105
2021 Q1	$680K	Buy	+49,375	New	+$684K	0.01%	156

Other funds holding NAUT

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

AH Equity Partners LSV II Menlo Park, California $95.6M AUM 8.86% 1-Year Est. Return